Archive for the ‘oncology retractions’ Category
A group of authors in China has retracted their December 2013 paper in PLoS ONE after realizing that they’d been studying the wrong cells.
The paper, “Up-Regulation of pVHL along with Down-Regulation of HIF-1α by NDRG2 Expression Attenuates Proliferation and Invasion in Renal Cancer Cells,” came from Lei Gao, of the Fourth Military Medical University, in Xi’an, and colleagues. It purported to find that:
Brutal honesty: Author takes to PubPeer to announce retraction — and tells us she’ll lose PhD, professorship
The comments suggested that the figures in the paper had problems. Some bands seemed to be duplicated, and one of the images looked very much like that of another paper.
The article, “PBOX-15 induces apoptosis and improves the efficacy of oxaliplatin in human colorectal cancer cell lines,” appeared in the European Journal of Pharmacology in August. The first author was Giuseppina Gangemi, of the University of Salerno.
The paper purported to find that:
The article, “Epigenetic aberrant methylation of tumor suppressor genes in small cell lung cancer,” was published in the August 2013 issue of the Journal of Thoracic Disease by authors from Shandong University in China.
A group of cancer researchers in China has lost their 2013 paper in the International Journal of Clinical and Experimental Pathology after someone tipped off the journal that the data were copied.
The article, “Importance of spondin 1 and cellular retinoic acid binding protein 1 in the clinical diagnosis of ovarian cancer,” came from Ting-Ting Jiao, Ye-Min Zhang, Lin Yao, Yuan Gao, Jian Sun, Dong-Fang Zou, Guo-Ping Wu, Dan Wang, Jun Ou, Ning Hui, who work at various Shanghai hospitals.
A group of researchers from MD Anderson Cancer Center in Houston has lost a 2013 paper in BJU International for running afoul of their institution’s ethics review board, and of military reviewers, as well.
The paper, “Many young men with prostate-specific antigen (PSA) screen-detected prostate cancers may be candidates for active surveillance,” looked at prostate cancer screening in men 55 and under — considered young for the older-man’s disease. According to the abstract: Read the rest of this entry »
The paper, “Different bone mineral density in cervical and endometrial cancer,” came from a group of Soonchunhyang University and was published online late last year. It purported to look at the association between gynecologic cancers and bone mineral density: Read the rest of this entry »